A novel Dual GLP-1/CCK Receptor Agonist Improves Cognitive Performance and Synaptogenesis in the 5 × FAD Alzheimer Mouse Model.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A novel Dual GLP-1/CCK Receptor Agonist Improves Cognitive Performance and Synaptogenesis in the 5 × FAD Alzheimer Mouse Model.
- Published In:
- Molecular neurobiology, 62(9), 11920-11934 (2025)
- Authors:
- Ma, He, Chang, Zhenghui, Sun, Hongyu, Ma, Dongrui, Li, Zhonghua, Hao, Li, Zhang, Zhenqiang, Hölscher, Christian, Zhang, Zijuan
- Database ID:
- RPEP-12360
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12360APA
Ma, He; Chang, Zhenghui; Sun, Hongyu; Ma, Dongrui; Li, Zhonghua; Hao, Li; Zhang, Zhenqiang; Hölscher, Christian; Zhang, Zijuan. (2025). A novel Dual GLP-1/CCK Receptor Agonist Improves Cognitive Performance and Synaptogenesis in the 5 × FAD Alzheimer Mouse Model.. Molecular neurobiology, 62(9), 11920-11934. https://doi.org/10.1007/s12035-025-05037-7
MLA
Ma, He, et al. "A novel Dual GLP-1/CCK Receptor Agonist Improves Cognitive Performance and Synaptogenesis in the 5 × FAD Alzheimer Mouse Model.." Molecular neurobiology, 2025. https://doi.org/10.1007/s12035-025-05037-7
RethinkPeptides
RethinkPeptides Research Database. "A novel Dual GLP-1/CCK Receptor Agonist Improves Cognitive P..." RPEP-12360. Retrieved from https://rethinkpeptides.com/research/ma-2025-a-novel-dual-glp1cck
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.